165 related articles for article (PubMed ID: 34696960)
21. High Content Imaging of Early Morphological Signatures Predicts Long Term Mineralization Capacity of Human Mesenchymal Stem Cells upon Osteogenic Induction.
Marklein RA; Lo Surdo JL; Bellayr IH; Godil SA; Puri RK; Bauer SR
Stem Cells; 2016 Apr; 34(4):935-47. PubMed ID: 26865267
[TBL] [Abstract][Full Text] [Related]
22. Proteomic Profiling of Native Unpassaged and Culture-Expanded Mesenchymal Stromal Cells (MSC).
Moravcikova E; Meyer EM; Corselli M; Donnenberg VS; Donnenberg AD
Cytometry A; 2018 Jul; 93(9):894-904. PubMed ID: 30211967
[TBL] [Abstract][Full Text] [Related]
23. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
[TBL] [Abstract][Full Text] [Related]
24. Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells.
Pelizzo G; Veschi V; Mantelli M; Croce S; Di Benedetto V; D'Angelo P; Maltese A; Catenacci L; Apuzzo T; Scavo E; Moretta A; Todaro M; Stassi G; Avanzini MA; Calcaterra V
BMC Cancer; 2018 Nov; 18(1):1176. PubMed ID: 30482160
[TBL] [Abstract][Full Text] [Related]
25. Microenvironmental cues enhance mesenchymal stem cell-mediated immunomodulation and regulatory T-cell expansion.
Kadle RL; Abdou SA; Villarreal-Ponce AP; Soares MA; Sultan DL; David JA; Massie J; Rifkin WJ; Rabbani P; Ceradini DJ
PLoS One; 2018; 13(3):e0193178. PubMed ID: 29513756
[TBL] [Abstract][Full Text] [Related]
26. Morphological landscapes from high content imaging reveal cytokine priming strategies that enhance mesenchymal stromal cell immunosuppression.
Andrews SH; Klinker MW; Bauer SR; Marklein RA
Biotechnol Bioeng; 2022 Feb; 119(2):361-375. PubMed ID: 34716713
[TBL] [Abstract][Full Text] [Related]
27. Comparison of immune modulatory properties of human multipotent mesenchymal stromal cells derived from bone marrow and placenta.
Sarıkaya A; Aydın G; Özyüncü Ö; Şahin E; Uçkan-Çetinkaya D; Aerts-Kaya F
Biotech Histochem; 2022 Feb; 97(2):79-89. PubMed ID: 33641543
[TBL] [Abstract][Full Text] [Related]
28. Stem cells isolated from the human stromal limbus possess immunosuppressant properties.
Garfias Y; Nieves-Hernandez J; Garcia-Mejia M; Estrada-Reyes C; Jimenez-Martinez MC
Mol Vis; 2012; 18():2087-95. PubMed ID: 22876135
[TBL] [Abstract][Full Text] [Related]
29. Strategies to address mesenchymal stem/stromal cell heterogeneity in immunomodulatory profiles to improve cell-based therapies.
Dunn CM; Kameishi S; Grainger DW; Okano T
Acta Biomater; 2021 Oct; 133():114-125. PubMed ID: 33857693
[TBL] [Abstract][Full Text] [Related]
30. Comparative analysis of human mesenchymal stem cells from bone marrow and adipose tissue under xeno-free conditions for cell therapy.
Li CY; Wu XY; Tong JB; Yang XX; Zhao JL; Zheng QF; Zhao GB; Ma ZJ
Stem Cell Res Ther; 2015 Apr; 6(1):55. PubMed ID: 25884704
[TBL] [Abstract][Full Text] [Related]
31. Heterogeneity of the biological properties and gene expression profiles of murine bone marrow stromal cells.
Lei J; Hui D; Huang W; Liao Y; Yang L; Liu L; Zhang Q; Qi G; Song W; Zhang Y; Xiang AP; Zhou Q
Int J Biochem Cell Biol; 2013 Nov; 45(11):2431-43. PubMed ID: 23911306
[TBL] [Abstract][Full Text] [Related]
32. Molecular and cellular characteristics of human and non-human primate multipotent stromal cells from the amnion and bone marrow during long term culture.
Pogozhykh O; Pogozhykh D; Neehus AL; Hoffmann A; Blasczyk R; Müller T
Stem Cell Res Ther; 2015 Aug; 6(1):150. PubMed ID: 26297012
[TBL] [Abstract][Full Text] [Related]
33. Differential immunomodulation of human mesenchymal stromal cells from various sources in an inflammation mimetic milieu.
Meenakshi Sundaram R; Kadapakkam Nandabalan S; Rupert S; Srinivasan P; Sankar P; Patra B; Verma RS; Vennila R; Sathyanesan J; Rajagopal S
Cytotherapy; 2022 Feb; 24(2):110-123. PubMed ID: 34740526
[TBL] [Abstract][Full Text] [Related]
34. Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells.
Siegel G; Kluba T; Hermanutz-Klein U; Bieback K; Northoff H; Schäfer R
BMC Med; 2013 Jun; 11():146. PubMed ID: 23758701
[TBL] [Abstract][Full Text] [Related]
35. Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact.
Ciccocioppo R; Cangemi GC; Kruzliak P; Gallia A; Betti E; Badulli C; Martinetti M; Cervio M; Pecci A; Bozzi V; Dionigi P; Visai L; Gurrado A; Alvisi C; Picone C; Monti M; Bernardo ME; Gobbi P; Corazza GR
Stem Cell Res Ther; 2015 Jul; 6(1):137. PubMed ID: 26206376
[TBL] [Abstract][Full Text] [Related]
36. Impact of starting material (fresh versus cryopreserved marrow) on mesenchymal stem cell culture.
Kaplan A; Sackett K; Sumstad D; Kadidlo D; McKenna DH
Transfusion; 2017 Sep; 57(9):2216-2219. PubMed ID: 28653392
[TBL] [Abstract][Full Text] [Related]
37. Identification and characterization of a large source of primary mesenchymal stem cells tightly adhered to bone surfaces of human vertebral body marrow cavities.
Johnstone BH; Miller HM; Beck MR; Gu D; Thirumala S; LaFontaine M; Brandacher G; Woods EJ
Cytotherapy; 2020 Nov; 22(11):617-628. PubMed ID: 32873509
[TBL] [Abstract][Full Text] [Related]
38. Characterization and profiling of immunomodulatory genes of equine mesenchymal stromal cells from non-invasive sources.
De Schauwer C; Goossens K; Piepers S; Hoogewijs MK; Govaere JL; Smits K; Meyer E; Van Soom A; Van de Walle GR
Stem Cell Res Ther; 2014 Jan; 5(1):6. PubMed ID: 24418262
[TBL] [Abstract][Full Text] [Related]
39. Activated T cells modulate immunosuppression by embryonic-and bone marrow-derived mesenchymal stromal cells through a feedback mechanism.
Lin W; Oh SK; Choo AB; George AJ
Cytotherapy; 2012 Mar; 14(3):274-84. PubMed ID: 22136295
[TBL] [Abstract][Full Text] [Related]
40. Induced Pluripotent Stem Cell-Derived Mesenchymal Stromal Cells Are Functionally and Genetically Different From Bone Marrow-Derived Mesenchymal Stromal Cells.
Xu M; Shaw G; Murphy M; Barry F
Stem Cells; 2019 Jun; 37(6):754-765. PubMed ID: 30779868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
